Nanofarma Development

Nanofarma Development Overview

Founded 2011
Founded
Status Acquired/​Merged
Latest Deal Type M&A
Financing Rounds 3

Nanofarma Development General Information

Description

Provider of drug development services. The company specializes in oral drug delivery systems based on nanotechnology. The system is a microcontainers made from specially degradable biopolymers, which have the ability to attach to specified parts of the gastrointestinal tract and protect the active ingredient from the destructive action of proteolytic enzymes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Izvarino Pharma
Primary Office
  • Vosstaniya ulitsa 100
  • Kazan, 420095
  • Russia
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanofarma Development Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanofarma Development‘s full profile, request access.

Request a free trial

Nanofarma Development Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nanofarma Development‘s full profile, request access.

Request a free trial